Estradiol/Norgestimate Shortage Update: What Patients Need to Know in 2026

If you're having trouble filling your Prefest prescription in 2026 and wondering whether there's an official shortage, here's what you need to know. The situation is nuanced — there is no active FDA-classified national shortage of Estradiol/Norgestimate tablets, but real-world access challenges are genuine and widespread for many patients. This update covers the current status, what's driving availability issues, and what you can do to stay on your therapy.

Current Shortage Status (2026)

As of 2026, Prefest (Estradiol/Norgestimate, manufactured by Teva Pharmaceuticals) is not listed on the FDA's official drug shortage database. This means the FDA has not determined that national supply has fallen to a critical level requiring emergency intervention.

However, patients across the country are reporting that their usual pharmacy either doesn't stock Prefest regularly, runs out frequently, or has back-ordered it. This gap between official status and patient experience is common for brand-only, specialty-use medications that have limited distribution.

Why Is It Hard to Find Prefest Even Without an Official Shortage?

Several factors contribute to real-world access problems for Prefest in 2026:

• Surging HRT demand: In late 2025, the FDA removed or softened boxed warnings on multiple hormone replacement therapy products. This triggered a significant jump in new HRT prescriptions as patients who previously avoided treatment reconsidered it. The entire HRT supply chain has been stressed as a result.
• Limited distribution of a brand-only product: Prefest has no generic equivalent. Teva Pharmaceuticals is the sole manufacturer, and distribution is handled through standard wholesale channels. If regional warehouse stock runs low, local pharmacies in that region may not have it.
• Low routine stocking priority: Prefest is prescribed to a relatively narrow patient population (postmenopausal women with an intact uterus who specifically need a combined oral HRT with an intermittent progestogen cycle). Many pharmacies don't keep it in regular stock and only order it by request.
• Overflow demand from transdermal HRT shortages: The well-documented shortage of transdermal estradiol patches in 2026 has pushed some patients toward oral HRT alternatives. This increased demand for oral HRT products puts additional pressure on products like Prefest.

A Timeline: HRT Availability in Recent Years

Understanding the recent history of HRT availability helps put Prefest's situation in context:

• Pre-2020: HRT use had declined significantly after the Women's Health Initiative (WHI) study results published in 2002 raised cancer and cardiovascular concerns. Prefest and similar products were niche items with low-volume demand.
• 2020–2024: Growing menopause awareness via social media and telehealth platforms caused HRT prescriptions to climb. Demand for products like Prefest gradually increased without a proportional increase in manufacturing capacity.
• Late 2025: The FDA removed boxed warnings from transdermal estradiol products, triggering a sharp prescription surge that caused widespread patch shortages. Some patients were redirected to oral HRT.
• 2026: Oral HRT products including Prefest face intermittent availability challenges at individual pharmacies, though no national emergency shortage has been declared.

Will Prefest Become More Available?

There is reason for cautious optimism. Manufacturing capacity for HRT products generally is being ramped up by multiple pharmaceutical companies in response to increased demand. However, scaling pharmaceutical manufacturing takes months — sometimes 6 to 18 months — so meaningful supply relief may not be immediate. For Prefest specifically, Teva continues to produce and distribute the product. The availability issues are primarily at the pharmacy stocking level, not a total supply collapse.

What Patients Should Do Right Now

Here's a practical action plan for patients who are having trouble filling Prefest:

1. Use medfinder: Go to medfinder.com to search for Prefest at pharmacies near you. medfinder calls pharmacies to check real-time stock and texts you the results.
2. Refill early: Start searching for your refill 10–14 days before you run out. This gives you time to find stock or request a special order.
3. Ask your pharmacy to order it: Most pharmacies can special-order Prefest even if they don't stock it routinely. Orders typically arrive within 1–3 business days.
4. Talk to your provider: If consistent access is a problem, your prescriber can discuss switching you to an alternative HRT that's more widely available. Do not stop HRT abruptly without medical guidance.
5. Consider mail-order: Mail-order pharmacies often maintain larger inventories of maintenance medications and offer 90-day supplies, reducing how often you need to fill.

The Bottom Line

Estradiol/Norgestimate (Prefest) is not in an official FDA shortage in 2026, but real-world access issues are genuine. The broader HRT demand surge and Prefest's brand-only status make it harder to find than many other HRT products. Stay ahead of your refills, use medfinder to check real-time availability near you, and keep an open conversation with your prescriber about alternatives if access remains a consistent challenge. For more information about alternatives, see our guide on alternatives to Estradiol/Norgestimate.